US-based biotechnology company Trishula Therapeutics has reported positive results from its Phase I clinical trial of TTX-030 ...

The "Virtual Clinical Trials Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's ...

Analyst Jason Butler of JMP Securities reiterated a Buy rating on Rezolute (RZLT – Research Report), retaining the price target of $7.00.

FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S.Phase 3 study for ...

Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient ...

Key Takeaways from the Mantle Cell Lymphoma Pipeline Report DelveInsight's mantle cell lymphoma pipeline ... AstraZeneca had announced positive interim results from the Phase III ECHO clinical trial, ...

Australia has a reputation as an attractive clinical trials destination generating $1.6bn for the economy in 2022, according ...

Promising Triple Negative Breast Cancer Pipeline Therapies in the various stages of development include Nanosomal Docetaxel ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced positive clinical results from BRACELET-1, its ...

NIH clinical trial results expand treatment options for this disease.